Results 201 to 210 of about 681,261 (380)

Safety and Efficacy of Long‐Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy

Haemophilia, EarlyView.
ABSTRACT Introduction Type 1 plasminogen deficiency (PLGD‐1), or hypoplasminogenaemia, is an ultra‐rare autosomal‐recessive disorder characterised by fibrin‐rich lesions on mucous membranes, often leading to serious complications if left untreated. Prior treatments have shown limited and inconsistent success, but IV PLG concentrate (Ryplazim) offers a ...
Amy D. Shapiro, Heather McDaniel, Robert W. Decker, Charles Nakar, Jeremy Lorber, Neelam Thukral, Joseph M. Parker, Karen Thibaudeau   +7 more
wiley   +1 more source

Human tissue-type plasminogen activator

Thrombosis and Haemostasis, 2014
E. Kruithof, S. Dunoyer-Geindre
semanticscholar   +1 more source

Uniqueness of plasminogen activators [PDF]

Nature, 1976
Judith K. Christman, George Acs
openaire   +3 more sources

Current Practice Regarding Bleeding Disorders of Unknown Cause in the Netherlands: A National Survey

Haemophilia, EarlyView.
ABSTRACT Introduction About 40%–70% of persons with a clinically relevant bleeding tendency who are referred to haemostasis experts are classified as having a ‘bleeding disorder of unknown cause’ (BDUC) as no biological entity can be found after extensive laboratory testing.
Caroline M. A. Mussert, Amaury L. L. Monard, Tirsa T. van Duijl, Yvonne M. C. Henskens, Maartje van den Biggelaar, Roger E. G. Schutgens, Saskia E. M. Schols, Karin J. Fijnvandraat, Karina Meijer, Paul L. den Exter, Laurens Nieuwenhuizen, Iris van Moort, Marieke J. H. A. Kruip, Marjon H. Cnossen, Floor C. J. I. Heubel‐Moenen, for the BDUC‐iN study group   +15 more
wiley   +1 more source

Plasminogen activator inhibitor 1 is a novel predictor in human serum/follicular fluid for diminished ovarian reserve. [PDF]

BMC Womens Health
Li X, Chen X, Guo H.
europepmc   +1 more source

Lysosomal cysteine proteinases as mediators of inflammation and tumor spread [PDF]

, 1992
Assfalg-Machleidt, Irmgard, Jochum, Marianne, Jänicke, F., Machleidt, W., Schmitt, M.   +4 more
core   +1 more source

Diffusion-, T₂-, and Perfusion-Weighted Nuclear Magnetic Resonance Imaging of Middle Cerebral Artery Embolic Stroke and Recombinant Tissue Plasminogen Activator Intervention in the Rat

, 1998
Quan Jiang, Rui Lan Zhang, Zheng Gang Zhang, James R. Ewing, George Divine, Michael Chopp   +5 more
openalex   +1 more source

Unmasking Convergent Inflammatory and Oxidative Pathways in Asthma

Allergy, EarlyView.
Konstantinos Tourlakopoulos, Georgios Mavrovounis, Lamprini Kontopoulou, Spyros Polyzois, Ioannis Pantazopoulos, Paraskevi Kirgou, Zoe Daniil, Konstantinos I. Gourgoulianis, Ourania S. Kotsiou   +8 more
wiley   +1 more source

Activation of the Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor System in Periodontitis: A Case–Control Study

International Journal of Dental Hygiene, EarlyView.
ABSTRACT Introduction The plasminogen activating (PA) system has a multitude of functions such as wound healing, proteolytic activity, collagen degradation and cell growth, and the role of the urokinase plasminogen activator/urokinase plasminogen activator receptor (uPA/uPAR) system has been studied in many disease states.
Ahmed Khudhur, Christopher Dowson, Susan M. Bissett, Rachel van de Merwe, John J. Taylor, Philip M. Preshaw, Katrin M. Jaedicke   +6 more
wiley   +1 more source

Magnesium, fibrinolysis and clotting interplay among children and adolescents with type 1 diabetes mellitus; potential mediators of diabetic microangiopathy. [PDF]

Nutr Diabetes
Toaima DN, Abdel-Maksoud KS, Atef HM, Salah NY.   +3 more
europepmc   +1 more source